News - Page 184

TLDR: Venture capital funds play a key role in funding biobased startups due to high levels of risk involved in bringing novel biomaterials to market. Three funds with significant bioeconomy investments are

TLDR: Louise Kingston has been promoted to partner at Baird Capital in London. She joined the firm as a director in January 2022. Baird Capital has announced the promotion of Louise Kingston

TLDR: HopSkip, a Philadelphia startup, raises $3 million in seed funding round from Conductive Ventures. Founded in 2019, the SaaS platform connects event planners with hotels and has seen significant growth. HopSkip,

TLDR: Michael Frazis, a Gen Y tech investor, has launched a venture capital fund and invested in software start-up Caresquare. Frazis has raised $10 million from high-net-worth investors and associates to invest

TLDR: Elias Terman appointed as Operating Partner at YL Ventures, a global cybersecurity venture capital firm. Terman brings cybersecurity marketing and business experience from his previous roles to help portfolio companies accelerate

TLDR: Seaya closed Seaya Andromeda, a €300 million climate-tech fund in Southern Europe. The fund focuses on impact-driven growth companies in energy transition, decarbonization, sustainable food value chain, and circular economy. Full

TLDR: Seaya, a venture capital firm based in Madrid, has closed Southern Europe’s first Article 9 climate-tech fund at €300M, with limited partners including Iberdrola, Nortia, Santander, BNP Paribas Group, Next Tech

TLDR: Seaya has launched a $320 million fund for growth-stage climate tech startups, making it the largest VC firm in Spain. The Seaya Andromeda fund will focus on startups in four key

TLDR: k-ID, a global compliance engine for online safety and privacy management, announced a $45 million Series A funding round. The funding round is led by Andreessen Horowitz and Lightspeed Venture Partners,

TLDR: Korean digital healthcare startup Endo Health secures pre-seed funding from top-tier US investors, including Andreessen Horowitz and Krew Capital The company plans to revolutionize chronic disease management with an AI-driven personalized